Collection

Advanced 2D nanomaterials for biomedical applications

Submission status
Open
Open for submission from
22 November 2022
Submission deadline
Ongoing
Two-dimensional (2D) nanomaterials, for instance layered double hydroxides, Mxenes, graphene and black phosphorus, have shown great potential in imaging, immunomodulation and therapy for major diseases. These materials are typically extremely small in one dimension and much larger in the other two dimensions, creating the ultrathin 2D nanomaterials with very high surface areas. They thus often have potent functional performance in terms of their chemical, electronic, and optical properties. The flexible physicochemical properties of 2D nanomaterials make them efficient drug delivery systems which have the potential to play a major role in diagnosing and treating diseases. 2D nanomaterials also hold significant potential to advance the fundamentals and applications for imaging and treating major diseases, and for the combination of therapeutic and diagnostic modalities in so-called theranostics. However, this field is still in its infancy, and much work remains. This special collection aims to better understand the role and use of 2D nanomaterials for biomedical applications. A selection of original research papers and reviews focusing on 2D nanomaterials for imaging, delivery and therapeutics with high clinical potential are sought. The subjects include, but are not limited to: 2D Nanomaterials for disease imaging or diagnosis 2D Nanomaterials for vaccine delivery or immunomodulation 2D Nanomaterials for targeted drug delivery Drug-free/low-loading 2D materials for biomedical applications 2D Nanomaterials-related toxicity

Editors

  • Weiyu Chen Weiyu Chen , 

    Weiyu Chen

    Dr. Weiyu Chen received his Ph.D. degree at The University of Queensland in 2018. Currently, he works at International Institution of Medicine, the Fourth Affiliated Hospital, Zhejiang University as a Professor and Deputy Director of PCCM. His research projects focus on cancer theranostics via molecular imaging and nanomedicine.

  • Lingxiao Zhang Lingxiao Zhang  &

    Lingxiao Zhang

    Dr. Lingxiao Zhang received his Ph.D. degree at University of Chinese Academy of Sciences in 2020. He is now an associate professor in Zhejiang University City College and Marie Sklodowska-Curie Actions Postdoctoral Fellow in Aarhus University. His research focuses on the development of two-dimensional clay materials-based nanobiotechnological drugs and nanovaccines for the diagnosis and therapy of malignant tumors and neurodegenerative diseases.

  • Gareth R. Williams Gareth R. Williams

    Gareth R. Williams

    Dr. Gareth R. Williams received a MChem (Hons) degree from the University of Oxford in 2002. He remained in Oxford for a DPhil (PhD), which was completed in 2005. He is now a Professor of Pharmaceutics at University College London and since 2020 has been Head of Pharmaceutics. Gareth leads a group of around 20 researchers applying inorganic and polymer-based nanomaterials to overcome drug delivery challenges.

Articles (38 in this collection)